4 Results for "

Labetuzumab

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Labetuzumab" in MCE Product Catalog:

Cat. No.: HY-P99160
CAS No.: 219649-07-7
Synonyms: hMN14

Research Areas:  

Cancer

Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy .
loading...
    loading...
Cat. No.: HY-128945
CAS No.: 2616704-22-2
Purity:  99.49%
Target:  

ADC Linkers

Research Areas:  

Inflammation/Immunology Cancer

CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker .
loading...
    loading...
Cat. No.: HY-P99681
CAS No.: 1469876-18-3
Synonyms: IMMU 130; hMN-14-SN-38
Research Areas:  

Cancer

Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38 antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer .
loading...
    loading...
Cat. No.: HY-128945A
Target:  

ADC Linkers

Research Areas:  

Inflammation/Immunology Cancer

CL2A TFA is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A TFA is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker .
loading...
    loading...